CONCORD biomarker prediction for novel drug introduction to different cancer types

Many cancer therapeutic agents have shown to be effective for treating multiple cancer types. Yet major challenges exist toward introducing a novel drug used in one cancer type to different cancer types, especially when a relatively small number of patients with the other cancer type often benefit f...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Youngchul, Dillon, Patrick M., Park, Taesung, Lee, Jae K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787421/
https://www.ncbi.nlm.nih.gov/pubmed/29416679
http://dx.doi.org/10.18632/oncotarget.23124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787421/
https://www.ncbi.nlm.nih.gov/pubmed/29416679
http://dx.doi.org/10.18632/oncotarget.23124

Ejemplares similares